{"id":"W3129514033","doi":"10.3389/fonc.2020.569715","title":"nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)","year":2021,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"Bristol-Myers Squibb","keywords":"Durvalumab; Medicine; Internal medicine; Docetaxel; Oncology; Clinical endpoint; Paclitaxel; Lung cancer; non-small cell lung cancer (NSCLC); Progression-free survival; Stage (stratigraphy); Chemotherapy; Adverse effect; Cancer; Nivolumab; Immunotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000893521,0.0002479773,0.0006988373,0.0002174795,0.00006337072,0.00001381061,0.00009221499,0.0001910877,0.0001447371],"category_scores_gemma":[0.00003818888,0.0002118884,0.00006419828,0.0005225582,0.00008459364,0.0001095986,0.00004055952,0.0002907761,0.00000455998],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004021429,"about_ca_system_score_gemma":0.002198077,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001089074,"about_ca_topic_score_gemma":0.003639906,"domain_scores_codex":[0.9982757,0.0001091325,0.0003887801,0.0005194977,0.0001880696,0.0005188051],"domain_scores_gemma":[0.9991248,0.00004233915,0.0001562311,0.0003309088,0.0001944001,0.0001512662],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001320857,0.001128683,0.9751416,0.0002048498,0.0002208025,0.0005455751,0.002970052,0.0007534868,0.00003542986,0.000007646646,0.003157727,0.01451324],"study_design_scores_gemma":[0.06340278,0.002396936,0.8819914,0.0005599547,0.0007197998,0.00000845561,0.002930037,0.001092261,0.0004680593,0.00002714739,0.04592663,0.0004765491],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9833179,0.003836702,0.0005087727,0.0004086652,0.0008852793,0.001614847,0.00008212438,0.00003538816,0.009310395],"genre_scores_gemma":[0.9566853,0.0009647731,0.01790974,0.0008263228,0.0000810022,0.0008900792,0.0004854868,0.0000785002,0.02207881],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09315026,"threshold_uncertainty_score":0.9998019,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006197421621776283,"score_gpt":0.3036336720379647,"score_spread":0.2974362504161884,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}